Camurus

Committed to developing and commercializing long-acting treatments for patients with severe and chronic diseases.

General Information
Company Name
Camurus
Founded Year
1991
Location (Offices)
Sweden +1
Founders / Decision Makers
Number of Employees
240
Industries
Health Care, Pharmaceutical
Funding Stage
Series Unknown
Social Media

Camurus - Company Profile

Camurus

Slogan: Committed to developing and commercializing long-acting treatments for patients with severe and chronic diseases.

Description: Camurus is a Swedish science-led biopharmaceutical company committed to developing and commercializing innovative and differentiated medicines for the treatment of severe and chronic conditions. New drug products with best-in-class potential are conceived based on the company’s proprietary FluidCrystal® drug delivery technologies and its extensive R&D expertise. Camurus’ clinical pipeline includes products for the treatment of opioid dependence and chronic pain, rare diseases, oncology, and supportive care, which are developed in-house and in collaboration with international pharmaceutical companies. The company’s shares are listed on Nasdaq Stockholm under the ticker CAMX.

Founded: 1991

Industries: Health Care, Pharmaceutical

Headquarter: Sweden

Last Investment: €54.00MVenture Round investment at 23 November 2015 by Erik Paulsson, Martin Gren

As a Swedish biopharmaceutical company, Camurus has established a strong presence in developing and commercializing long-acting treatments for severe and chronic diseases. With a diverse clinical pipeline and proprietary FluidCrystal® drug delivery technologies, they offer innovative solutions in the areas of opioid dependence, chronic pain, rare diseases, oncology, and supportive care. Their successful listing on Nasdaq Stockholm and the support from investors such as Erik Paulsson and Martin Gren indicate a promising trajectory for the company in the health care and pharmaceutical industries.

Taxonomy: Biopharmaceutical, Drug delivery technologies, R&D expertise, Opioid dependence treatment, Rare diseases, Nasdaq Stockholm, Specialty medicines, Chronic conditions, Innovative treatments, Swedish company

Funding Rounds & Investors of Camurus (1)

View All
Funding Stage Amount No. Investors Investors Date
Venture Round €54.00M 2 Erik Paulsson, Martin Gren 23 Nov 2015

Latest News of Camurus

View All

No recent news or press coverage available for Camurus.

Similar Companies to Camurus

View All
LANCET Pharmaceuticals - Similar company to Camurus
LANCET Pharmaceuticals ON THE CUTTING EDGE OF MEDICAL TECHNOLOGIES
TikoMed AB - Similar company to Camurus
TikoMed AB Developing game changing treatments and cell therapies for severe diseases.
Luna Medical, Inc. - Similar company to Camurus
Luna Medical, Inc. We're so SWELL--you don't have to be. Compression WEAR it counts!
Allure Dental Studio - Similar company to Camurus
Allure Dental Studio A full service, technology-based dental laboratory with a full array of products and services. (877) 325-5873
CyberLiver - Similar company to Camurus
CyberLiver Pioneer in Digital Medicine and Digital Therapeutics for the treatment of advanced liver disease